Form 8-K - Current report:
SEC Accession No. 0001493152-21-031141
Filing Date
2021-12-10
Accepted
2021-12-10 16:55:03
Documents
13
Period of Report
2021-12-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38066
2 ex3-1.htm EX-3.1 131779
  Complete submission text file 0001493152-21-031141.txt   373815

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20211210.xsd EX-101.SCH 3022
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20211210_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20211210_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3727
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 211486027
SIC: 2834 Pharmaceutical Preparations